The mediation proportions of SGLT2 inhibition through polyunsaturated fatty acids and omega-6 fatty acids concerning colorectal cancer were 2.388% and 2.131% of the total effect, respectively. The gene discussed is SLC5A2; the disease is colorectal cancer.